David Bharucha's Insider Trades & SAST Disclosures

David Bharucha's most recent trade in Milestone Pharmaceuticals Inc was a trade of 53,333 Series B Common Warrants (right to buy) done . Disclosure was reported to the exchange on July 11, 2025.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Milestone Pharmaceuticals Inc
David Bharucha Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jul 2025 53,333 53,333 - - Series B Common Warrants (right to buy)
Milestone Pharmaceuticals Inc
David Bharucha Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jul 2025 53,333 63,333 (0%) 0% - Common Shares
Milestone Pharmaceuticals Inc
David Bharucha Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jul 2025 53,333 53,333 - - Series A Common Warrants (right to buy)
Milestone Pharmaceuticals Inc
David Bharucha Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Jan 2025 120,600 120,600 - - Employee Stock Option (right to buy)
Milestone Pharmaceuticals Inc
David Bharucha Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Jan 2025 80,400 80,400 - - Restricted Stock Unit
Milestone Pharmaceuticals Inc
David Bharucha Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Feb 2023 185,000 185,000 - - Employee Stock Option (right to buy)
Milestone Pharmaceuticals Inc
David Bharucha Chief Medical Officer Purchase of securities on an exchange or from another person at price $ 4.69 per share. 01 Dec 2022 7,000 10,000 (0%) 0% 4.7 32,830 Common Shares
Milestone Pharmaceuticals Inc
David Bharucha Chief Medical Officer Purchase of securities on an exchange or from another person at price $ 4.86 per share. 01 Dec 2022 3,000 3,000 (0%) 0% 4.9 14,580 Common Shares
Milestone Pharmaceuticals Inc
David Bharucha Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Feb 2022 330,000 330,000 - - Employee Stock Option (right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades